03:26 AM EDT, 09/08/2025 (MT Newswires) -- Sarah Boyce, Director, President and Chief Executive Officer, on September 05, 2025, sold 50,000 shares in Avidity Biosciences ( RNA ) for $2,497,435. Following the Form 4 filing with the SEC, Boyce has control over a total of 305,871 common shares of the company, with 305,871 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1599901/000159990125000175/xslF345X05/wk-form4_1757112957.xml